NPPES file of Aug 9, 2026

James L. Rubenstein, MD

Medical Oncology Physician · San Francisco, CA

James L. Rubenstein, MD is a medical oncology physician with a practice address in San Francisco, California, and NPI 1972552784, issued on May 9, 2006. Check the license (California G78262, as entered in NPPES) on the Medical Board of California; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2023 and 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1972552784
Name
James L. Rubenstein
Credential
MD
Primary taxonomy
Medical Oncology Physician 207RX0202X
License number
G78262 CA
Self-reported in NPPES; status is on the state search
Practice location
400 Parnassus Ave, San Francisco, CA 94143
Phone
(415) 353-2421
Enumerated
May 9, 2006
Record last updated
Jul 13, 2026
Fax
(415) 353-2467
Medicaid ID
00G782620 CA
Medicare enrollment
Enrolled (PECOS I20080216000086); accepts Medicare assignment
Medical or professional school
Js Weill Medical College, Cornell University, 1992
Telehealth
Offers telehealth (CMS)
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 400 Parnassus Ave

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Jessica Abele, DPTPhysical Therapist1851648133
  2. Ian Adatia, MB CHBPediatric Cardiology Physician1427085299
  3. Daniel Adelman, M.D.Internal Medicine Physician1922041821
  4. Joshua Adler, MDInternal Medicine Physician1194781351
  5. Justin Ahn, M.D.Urology Physician1063755148
  6. Weiyun Ai, MDMedical Oncology Physician1649346842

Verify James L. Rubenstein in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersMedical Board of California
    Search for license G78262
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the California license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

11% fewer Medicare Part D claims than the average medical oncology physician in 2024

626 Medicare Part D claims for 54 beneficiaries, against an average of 703 among the 4,230 providers of this specialty who prescribed in Part D. Brand-name drugs were 44% of claims.

  1. James Rubenstein626
  2. Specialty average703

Most prescribed

  1. Acyclovir92 claims
  2. Revlimid87 claims
  3. Imbruvica79 claims
  4. Pomalyst50 claims
  5. Sulfamethoxazole-Trimethoprim47 claims
  6. Lenalidomide36 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 74.5 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

  1. Qualitynot scored (reweighted)
  2. Costout of 100 · 30%46.7
  3. Promoting interoperabilityout of 100 · 25%76.0
  4. Improvement activities40 of 40 points · 15%100.0

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $50.92

2 payments; by number, the most common kind was food and beverage; the largest payer was Genmab U.S., Inc. The 3,343 providers of this specialty with any payment received $11,773.47 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. James Rubenstein$51
  2. Specialty average$11,773

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through 3 group practices

  1. Regents OF The University OF CaliforniaSan Francisco, CA
  2. Ucsf Medical Group Business ServicesBerkeley, CA
  3. University OF California San FranciscoSan Francisco, CA

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

James L. Rubenstein among 447 medical oncology physician records in California

James L. Rubenstein, MD is one of 447 medical oncology physician records with a practice address in California. 82% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2006, is newer than 6% of them.

  • NPI issued2006 · 6% of these records are older, 55% newer
  • In a Medicare fileYes · 82% of these records are
  • In the CMS Doctors and Clinicians fileYes · 70% of these records are
  • Graduated1992 · median 2004 among the 312 with a school on file
  • Record last updated2026 · 41% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RX0202X and a California practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

Medical Oncology Physician providers in California

There are 447 medical oncology physician records in California.

The 8 medical oncology physician records with the nearest ZIP codes

  1. Donald Abrams, MDSan Francisco, CA 941431679530018
  2. Weiyun Ai, MDSan Francisco, CA 941431649346842
  3. Rohit Bose, M.D., PH.D.San Francisco, CA 941431710140850
  4. Edward Cha, M.D.San Francisco, CA 941431134330988
  5. Lloyd Damon, MDSan Francisco, CA 941431548224058
  6. Steven Deeks, MDSan Francisco, CA 941431073604666
  7. Kristen Hege, MDSan Francisco, CA 941431710925987
  8. Gerald Hsu, MDSan Francisco, CA 941431467501080

Common questions

What is James L. Rubenstein, MD's NPI number?

James L. Rubenstein, MD's National Provider Identifier (NPI) is 1972552784, issued on May 9, 2006. An NPI identifies a provider in billing; it is not a license.

Where is James L. Rubenstein, MD located?

The NPPES record lists a practice address at 400 Parnassus Ave, San Francisco, CA, 94143. Phone: (415) 353-2421. Providers update this record themselves, so call before visiting.

How can I verify James L. Rubenstein, MD's license?

NPPES lists California license number G78262, as entered by the provider. Search the Medical Board of California at https://www.mbc.ca.gov/License-Verification/default.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does James L. Rubenstein, MD prescribe under Medicare Part D?

In 2024, James L. Rubenstein, MD had 626 Medicare Part D claims for 54 beneficiaries; the average among medical oncology physician prescribers was 703. Part D covers Medicare prescriptions only.

What is James L. Rubenstein, MD's MIPS final score?

The 2023 MIPS final score is 74.5 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.